<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The immunolocalization of oxidized <z:chebi fb="2" ids="39026">low-density lipoproteins</z:chebi> (ox-<z:chebi fb="15" ids="39026">LDL</z:chebi>), beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta(2)GPI), CD4(+)/CD8(+) immunoreactive lymphocytes, and immunoglobulins in <z:mp ids='MP_0005338'>atherosclerotic lesions</z:mp> strongly suggested an active participation of the immune system in atherogenesis </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> leading to ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> production is thought to play a central role in both the initiation and progression of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> is highly proinflammatory and chemotactic for macrophage/monocyte and immune cells </plain></SENT>
<SENT sid="3" pm="."><plain>Enzyme-linked immunosorbent assays (ELISAs) to measure circulating ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> have been developed and are being currently used to assess <z:mp ids='MP_0003674'>oxidative stress</z:mp> as risk factor or marker of atherosclerotic disease </plain></SENT>
<SENT sid="4" pm="."><plain>ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> interacts with beta(2)GPI and circulating ox-<z:chebi fb="15" ids="39026">LDL</z:chebi>/beta(2)GPI complexes have been demonstrated in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="5" pm="."><plain>It has been postulated that beta(2)GPI binds ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> to neutralize its proinflammatory and proatherosclerotic effects </plain></SENT>
<SENT sid="6" pm="."><plain>Because beta(2)GPI is ubiquitous in plasma, its interaction with ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> may mask oxidized <z:chebi fb="0" ids="53000">epitopes</z:chebi> recognized by capture antibodies potentially interfering with immunoassays results </plain></SENT>
<SENT sid="7" pm="."><plain>The measurement of ox-<z:chebi fb="15" ids="39026">LDL</z:chebi>/beta(2)GPI complexes may circumvent this interference representing a more physiological and accurate way of measuring ox-<z:chebi fb="15" ids="39026">LDL</z:chebi> </plain></SENT>
</text></document>